RPG Life Sciences Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Yugal Kishor Sikri
Algemeen directeur
₹47.8m
Totale compensatie
| Percentage CEO-salaris | 69.5% |
| Dienstverband CEO | 6.1yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 6.1yrs |
| Gemiddelde ambtstermijn bestuur | 6.7yrs |
Recente managementupdates
Recent updates
There May Be Some Bright Spots In RPG Life Sciences' (NSE:RPGLIFE) Earnings
Nov 15
RPG Life Sciences Limited's (NSE:RPGLIFE) Shares Climb 26% But Its Business Is Yet to Catch Up
Oct 18Investors Appear Satisfied With RPG Life Sciences Limited's (NSE:RPGLIFE) Prospects As Shares Rocket 30%
Jul 25RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality
May 08RPG Life Sciences (NSE:RPGLIFE) Is Increasing Its Dividend To ₹12.00
Jul 11Estimating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Sep 05Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now
Aug 24A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jun 14Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?
Feb 09Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?
Jan 13RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?
Dec 23
Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?
Nov 11Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Oct 21Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?
Sep 28What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?
Aug 31With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For
Aug 11What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E
Jul 28Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jul 10Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹707m |
| Jun 30 2024 | n/a | n/a | ₹923m |
| Mar 31 2024 | ₹48m | ₹33m | ₹877m |
| Dec 31 2023 | n/a | n/a | ₹848m |
| Sep 30 2023 | n/a | n/a | ₹774m |
| Jun 30 2023 | n/a | n/a | ₹715m |
| Mar 31 2023 | ₹39m | ₹27m | ₹676m |
| Dec 31 2022 | n/a | n/a | ₹648m |
| Sep 30 2022 | n/a | n/a | ₹603m |
| Jun 30 2022 | n/a | n/a | ₹561m |
| Mar 31 2022 | ₹39m | ₹27m | ₹515m |
| Dec 31 2021 | n/a | n/a | ₹509m |
| Sep 30 2021 | n/a | n/a | ₹491m |
| Jun 30 2021 | n/a | n/a | ₹445m |
| Mar 31 2021 | ₹39m | ₹24m | ₹400m |
| Dec 31 2020 | n/a | n/a | ₹361m |
| Sep 30 2020 | n/a | n/a | ₹311m |
| Jun 30 2020 | n/a | n/a | ₹297m |
| Mar 31 2020 | ₹22m | ₹21m | ₹290m |
| Dec 31 2019 | n/a | n/a | ₹276m |
| Sep 30 2019 | n/a | n/a | ₹249m |
| Jun 30 2019 | n/a | n/a | ₹173m |
| Mar 31 2019 | ₹22m | ₹11m | ₹108m |
| Dec 31 2018 | n/a | n/a | ₹105m |
| Sep 30 2018 | n/a | n/a | ₹107m |
| Jun 30 2018 | n/a | n/a | ₹149m |
| Mar 31 2018 | ₹375k | n/a | ₹135m |
Compensatie versus markt: De totale vergoeding ($USD 566.43K ) Yugal Kishor } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 264.36K ).
Compensatie versus inkomsten: De beloning van Yugal Kishor is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.
CEO
Yugal Kishor Sikri (67 yo)
6.1yrs
Tenure
₹47,844,000
Compensatie
Mr. Yugal Kishor Choturam Sikri has been Managing Director and Director at RPG Life Sciences Limited since October 1, 2018 He served as an Independent & Non-Executive Director at RPG Life Sciences Limited...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Director | 6.1yrs | ₹47.84m | geen gegevens | |
| Chief Financial Officer | 4.3yrs | geen gegevens | geen gegevens | |
| Head of Legal | 13yrs | geen gegevens | geen gegevens | |
| Vice President of Sales & Marketing (Main Division) | no data | geen gegevens | geen gegevens | |
| Head of API Operations & Procurement | 7.6yrs | geen gegevens | geen gegevens | |
| Site Head of International Formulation | no data | geen gegevens | geen gegevens | |
| Chief Quality Officer | 5.8yrs | geen gegevens | geen gegevens |
6.1yrs
Gemiddelde duur
Ervaren management: Het managementteam van RPGLIFE is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.1 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Director | 8.3yrs | ₹47.84m | geen gegevens | |
| Chairman of the Board | 30.9yrs | ₹400.00k | 0.16% ₹ 54.7m | |
| Non-Executive Non-Independent Director | 20.3yrs | ₹400.00k | geen gegevens | |
| Non-Executive Director | 3.8yrs | ₹770.00k | geen gegevens | |
| Independent Non-Executive Director | 9.8yrs | ₹400.00k | 0.0089% ₹ 3.0m | |
| Independent & Non-Executive Director | 9.1yrs | ₹315.00k | geen gegevens | |
| Additional Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | 5.1yrs | ₹530.00k | geen gegevens | |
| Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens |
6.7yrs
Gemiddelde duur
56.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van RPGLIFE wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.7 jaar).